These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1032352)

  • 1. In vitro estrogen-binding by human breast carcinomas.
    Mobbs BG; Johnson IE
    Can Med Assoc J; 1976 Feb; 114(3):216-9. PubMed ID: 1032352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.
    Meyer JS; Bauer WC; Rao BR
    Lab Invest; 1978 Sep; 39(3):225-35. PubMed ID: 213652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol receptor levels in human breast carcinomas.
    Bird CE; Houghton B; Westenbrink W; Tenniswood M; Sterns EE; Clark AF
    Can Med Assoc J; 1981 Apr; 124(8):1010-2. PubMed ID: 7260784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
    Keshgegian AA; Cnaan A
    Arch Pathol Lab Med; 1996 Oct; 120(10):970-3. PubMed ID: 12046611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.
    Foster BD; Cavener DR; Parl FF
    Cancer Res; 1991 Jul; 51(13):3405-10. PubMed ID: 2054780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear estradiol-binding sites in human breast cancer.
    Vandewalle B; Peyrat JP; Bonneterre J; Hecquet B; Dewailly D; Lefebvre J
    Cancer Res; 1983 Sep; 43(9):4497-503. PubMed ID: 6683589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
    Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
    Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
    Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors.
    Johnston SR; Lu B; Dowsett M; Liang X; Kaufmann M; Scott GK; Osborne CK; Benz CC
    Cancer Res; 1997 Sep; 57(17):3723-7. PubMed ID: 9288779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen value as a marker in breast cancer.
    Narita D; Cimpean AM; Anghel A; Raica M
    Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochemical detection of estrogen receptors in mammary tumours.
    Gădăleanu V; Gavrilescu TH
    Morphol Embryol (Bucur); 1985; 31(1):31-4. PubMed ID: 3157051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7).
    McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME
    Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of estradiol-17 beta receptors in tumorous breast tissue as an index of the hormonal dependence of the tumor].
    Vitova GIa; Olinia AIa; Grabovskaia IK; Priedite IIu
    Vopr Onkol; 1979; 25(5):23-5. PubMed ID: 462848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Steroid hormone receptors in the normal breast and in benign mastopathies].
    Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
    Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
    [No Abstract]   [Full Text] [Related]  

  • 18. [New method for the determination of estrogen and progesterone receptors in human breast cell lines].
    Olea N; Devleeschower N; Leclercq G
    Rev Esp Fisiol; 1985 Dec; 41(4):373-80. PubMed ID: 4095360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A correlation between oestrogen receptors and tumour size in primary breast cancer.
    Kaplan O; Skornick Y; Greif F; Klausner Y; Rozin RR
    Eur J Surg Oncol; 1985 Dec; 11(4):357-60. PubMed ID: 4065348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.